Gray Market Peptides: So Much Hype, So Little Data FDA Removes Key Peptides from Category 2: What This Means for You FDA Peptide Transparency Scandal 2026: Who's Really Controlling BPC 157, TB 500 & More? YouTube Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # FDA Removes 12 Peptides from 503A Category 2 : r us_pharmacies